MHRA Blog - Increasing the efficiency of your clinical trial authorisation (CTA) application and reducing the need for subsequent substantial amendments

30th November 2022

MHRA

Increasing the efficiency of your clinical trial authorisation (CTA) application and reducing the need for subsequent substantial amendments

In this blog Graham McNaughton and Martin O'Kane describe ways to facilitate the review of your initial application, how to avoid unnecessary amendments and, where substantial amendments are necessary, how to submit these so that the review is as efficient as possible, leading to improved chances of approval.

Read Now

Back to News Archive